-
srdrplus.ahrq.gov/published_projects?page=48
October 31, 2022 - treatments for patients with binge-eating disorder (BED) and bariatric surgery patients and children with loss-of-control … Behavioral weight loss treatment produced greater weight loss than CBT at the end of treatment but not
-
srdrplus.ahrq.gov/published_projects?page=39
June 27, 2021 - Objectives: Background: Glaucoma is a multifactorial optic neuropathy characterized by an acquired loss … of retinal ganglion cells at levels beyond normal age-related loss and corresponding atrophy of the
-
srdrplus.ahrq.gov/published_projects?page=11
October 25, 2022 - ] 1.20 to 7.12, I2=76%; absolute risk difference [ARD] 10%), <15 letters (3 lines) of visual acuity loss … AMD (3 trials, N=2,445 people, odds ratio [OR] 0.72, 95% CI 0.58 to 0.90) and >3 lines visual acuity loss … trials, N=3,790 people, OR 0.83, 95% CI 0.70 to 0.98) and decreased risk of >3 lines visual acuity loss … ] 1.20 to 7.12, I2=76%; absolute risk difference [ARD] 10%), <15 letters (3 lines) of visual acuity loss … trials, N=3,790 people, OR 0.83, 95% CI 0.70 to 0.98) and decreased risk of >3 lines visual acuity loss
-
srdrplus.ahrq.gov/published_projects?page=36
June 27, 2021 - progressive damage to the optic nerve, deterioration of retinal ganglion cells and ultimately visual field loss
-
srdrplus.ahrq.gov/published_projects?page=26
June 27, 2021 - applicability of studies were limited due to study design, poor reporting of statistical outcomes, and loss … applicability of studies were limited due to flawed study design, poor reporting of statistical outcomes, and loss
-
srdrplus.ahrq.gov/published_projects?page=27
June 27, 2021 - Less than half of the studies reported loss of PTSD diagnosis or clinically meaningful response/remission
-
srdrplus.ahrq.gov/published_projects?page=19
June 27, 2021 - intermediate outcomes, such as virologic suppression and hepatitis B e antigen or hepatitis B surface antigen loss